Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Valsartan Related Compound A Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111013018 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
30 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-3018 30 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-3018 Supplier MilliporeSigma Supelco Supplier No. PHR187530MG
Only null left
Add to Cart
Add to Cart
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Valsartan Related Compound A is an impurity of valsartan, an orally active specific angiotensin II receptor blocker or angiotensin-II antagonist, which is widely used in treating hypertension by lowering the blood pressure.
TRUSTED_SUSTAINABILITY

Specifications

Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C24H29N5O3
MDL Number MFCD18252868
Synonym D-Valsartan; N-VALERYL-N-{[2′-(1 HTETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-D-VALINE(ent-Valsartan); (R)-N-Valeryl-N-([2′-(1 H-tetrazole-5-yl)-biphenyl-4-yl]methyl)valine; N-(1-Oxopentyl)-N-[[2′-(2 H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-D-valine
Type Certified Reference Material
Quantity 30 mg
Formula Weight 435.52
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.